翻訳と辞書
Words near each other
・ Cusk (fish)
・ Cusk-eels
・ Cuslett Formation
・ CUSO (disambiguation)
・ Cuso International
・ Cusop
・ Cusp
・ Cusp (anatomy)
・ Cusp (astrology)
・ Cusp (novel)
・ Cusp (singularity)
・ Cusp Conference
・ Cusp form
・ Cusp neighborhood
・ Cusp of Carabelli
CUSP9
・ Cuspate foreland
・ CUSPEA
・ Cuspia (gens)
・ Cuspicephalus
・ Cuspidal representation
・ Cuspidariidae
・ Cuspidata
・ Cuspidata anthracitis
・ Cuspidata bidens
・ Cuspidata castanea
・ Cuspidata ditoma
・ Cuspidata hypomelas
・ Cuspidata leptozona
・ Cuspidata micaria


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

CUSP9 : ウィキペディア英語版
CUSP9
CUSP9 is one of several cancer treatment protocols using re-purposed older drugs to interfere with cancer cell's growth rather than directly killing them with cytotoxic drugs.〔CUSP9
* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget. 2014;5(18):8052-82. PubMed PMID 25211298.〕〔A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget. 2013;4(4):502-30. PubMed PMID 23594434; PubMed Central PMCID: PMC3720600.〕 CUSP9 is a treatment specifically targeted to treating glioblastoma that uses growth factor inhibition by nine non-cytotoxic drugs to block growth along with a traditional cancer cell killing drug, temozolomide. CUSP9 is related to the COMBAT regimen〔Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience. Oncology. 2012;82(5):249-60. .〕 for treating various advanced pediatric cancers that uses two re-purposed non-cytotoxic drugs to augment two traditional cytotoxic drugs, or the GLAD regimen〔Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis. Neoplasia. 2013;15(5):481-90. PubMed PMID 23633920; PubMed Central PMCID: PMC3638351.〕 that uses one traditional anti-cancer drug, gefitinib, with three re-purposed non-cancer drugs. The ReDO project〔Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP, Vikas P. The Repurposing Drugs in Oncology (ReDO) Project. ecancermedicalscience. 2014;8:442. .〕 also follows this line of thought in cancer treatment.
None of these treatment regimens have been proven to be safe or effective in human cancers but are occasionally tried on compassionate-use basis in patients who have exhausted all other options. A formal trial of the CUSP9 protocol in recurrent glioblastoma is starting in Ulm, Germany.〔(【引用サイトリンク】title=CUSP9
*, 9 nine repurposed drugs, glioblastoma, temozolomide - Anticancer Fund )

==References==


抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「CUSP9」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.